Bioprocess validation market size was valued at $265.15 million in 2019 and is anticipated to grow $410.80 million till the year 2027, witnessing a CAGR of 5.5% from 2020 to 2027. Bioprocess validation involves several different activities carried out in testing for maintaining the preferred compliance level at all stages. Under bioprocess validation, assessment of active pharmaceutical elements and some contaminants like endotoxin, mycoplasma, and bacteria needs to be done. Specifically, first data is collected, assessed and afterward documented from each stage of a particular project at all the crucial levels. By working this way, bioprocess validation gives scientific proof about its capability of constantly bringing quality products. Consequently efficient process validation greatly contributes in increasing the efficacy, quality and safety of the drug. This market report is a thorough analysis of the medical industry along with providing global market trend analysis. The goal of this market report is to present the overview of the market by doing thorough market categorization on the basis of geography, process component, test and end user. It further gives information about prominent key players operating in the bioprocess validation market along with their place in the market. This report also depicts a few key trends as well as opportunities available in the market.
Bioprocess Validation Market Dynamics
Quality and stringent safety rules administering testing and product certification in the health related industries and increasing demand for bioprocess validation services outsourcing are two major factors to drive the market growth. Filter elements section is evaluated to record increasing demand during the forecast period because of the huge use of several different filters in bioprocess. These filters work greatly and increase the safety as well as efficacy of biopharmaceutical products, which serve as the prominent market driving segment.
Bioprocess Validation Market Categorization
This market is categorized based on the test type process component, geography and end user. On the basis of test type, the market is categorized into Leachables and Extractables, Microbiology Testing and Integrity Testing. On the basis of Process Component, the market is categorized into Bioreactors and Filter element. On the basis of End-User, the market is segmented into Pharmaceutical, CDMO and Biotechnology companies. Pharmaceutical companies among others are anticipated to obtain huge market share till 2025 due to the increasing biopharmaceuticals production and governing rules for checking the quality and validity of bioprocess. It forecasts about market size and forecast evaluations for the period 2017-2027 with respect to prominent regions such as Europe, Asia pacific, North America, South & Central America and Middle east and Africa. The market is later sub sectioned by each region by relevant countries and sections. The bioprocess validation is facing an increasing demand from rising economies like India and China. Asia Pacific is evaluated to obtain huge market share till 2025 because of the growing number of biopharmaceutical manufacturing industries operating in Asian countries and increasing demand for outsourcing bioprocess validation.
Competitive Analysis – Bioprocess Validation Market
Key developments are covered in this market report like organic and inorganic growth strategies. Several companies are there giving importance to organic growth strategies like product approvals, launches and others like events and patents. Collaborations, acquisitions and partnership are the inorganic growth strategies observed in the market. These strategies help market players to expand their business and customer base too. This report consists of profiles of some crucial bioprocess validation market industries and market strategies. Further, it also depicts the prominent key players of the market with information like company profiles, financial data about last three years, components services provided and key developments. Below is given the list of some key players operating in the bioprocess validation market.
- Pall Corporation (A Part of Danaher Corporation)
- Meissner Filtration Products, Inc.
- Merck KGaA
- SGS S.A.
- Sartorius Stedim Biotech S.A.
- Doc S.R.L.
- Eurofins Scientific
- Cobetter Filtration Equipment Co., Ltd.
- Toxikon Corporation
Furthermore, launching of new drug in the pharmaceutical segment and increasing use of sophisticated facilities in the pharmaceutical industry are propelling the bioprocess validation market growth.